Health · Pharma & Biotech · 8 hrs ago
FDA Warns Amazon Over Unapproved Herpes Treatments
The FDA warned Amazon for selling treatments for herpes that the agency has not approved.
The warning concerns products offered on Amazon.
Jeffrey Klausner, a physician with Herpes Cure Advocacy, called the products “quack medicines.”
His criticism reflects concern about the public being exposed to treatments that lack FDA approval.
The warning matters because shoppers may encounter these products while looking for herpes treatment.
No further action or response is described.
The FDA warned Amazon for selling unapproved herpes treatments.
The warning drew criticism from Jeffrey Klausner of Herpes Cure Advocacy.
Klausner said the public should not be subject to the treatments.
The source does not provide details about the treatments or Amazon’s response.
- Who
- The FDA warned Amazon.
- What
- The warning concerned Amazon selling unapproved herpes treatments.
- When
- Not stated.
- Where
- Amazon; the location is not stated.
- Why
- The FDA warned Amazon over selling unapproved herpes treatments.
This story does not have two clearly opposing sides.
The public should not be subject to these quack medicines.
This story does not have a timeline yet.
- Agency
- FDA
- Company
- Amazon
- Treatments
- Unapproved herpes treatments
- Critic
- Jeffrey Klausner of Herpes Cure Advocacy
Sources
Related news
Pilot trial tests support to limit weight regain after GLP-1 drugs stop
Dong-A launches three ibuprofen-based cold medicines
Experimental injection reduced visceral fat by 12% in early trials
FDA approves atezolizumab with chemotherapy for some stage III colon cancers
Review links drug company gifts to more and less appropriate prescribing
Brazil suspends Peptistrong supplement and orders all batches recalled
AstraZeneca blames trial design for failed bone disease drug study
Spain withdraws five erectile dysfunction supplements containing undeclared drugs
Baby Sleep Gripe Water Recalled After Alcohol Found in Testing
Possible Wrong Dose Raises Questions for PDE9 Drug Trials in Heart Failure
Experimental eye drops improve vision in a small study of a rare eye disease
